# SARCULATOR vs HemeOncBuddy

The clearest difference is rating: HemeOncBuddy at 5.0 against SARCULATOR's 4.3. HemeOncBuddy also leads on ratings volume (19 vs 3). SARCULATOR's advantage is update cadence (every 6 months vs every 24 months). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

HemeOncBuddy holds the better App Store score, 5.0 against 4.3. That said, the two scores are not equally well evidenced: HemeOncBuddy has 19 ratings behind it against 3, so its average is the more settled of the two.

SARCULATOR ships an update every 6 months, HemeOncBuddy every 24 months. The most recent releases landed on November 2, 2026 and November 7, 2026 respectively.

## The numbers

| Metric | SARCULATOR | HemeOncBuddy |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.3 (3 ratings)](https://appshunter.io/ios/app/sarculator/id1052119173/reviews) | **[5.0 (19 ratings)](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews)** |
| Number of ratings | 3 | **19** |
| Positive reviews | — | 100.0% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 6 months** | Every 24 months |
| Monetization | Free | Free |
| Size | 29 MB | 16 MB |
| Requires iOS | 15.0 | 15.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 17+ |
| Developer | [DIGITAL FOREST SRL](https://appshunter.io/developer/581246108) | [Veli Bakalov](https://appshunter.io/developer/1579207338) |

## What reviewers say

### SARCULATOR

[App page](https://appshunter.io/ios/app/sarculator/id1052119173)

This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.

**Highlights:** Predictive models for sarcoma patients, Estimates 5-year overall survival, Estimates 5-year disease-free survival, Estimates 10-year overall survival, Estimates cumulative incidence of distant metastasis, Informative tool for physicians

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### HemeOncBuddy

[App page](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336)

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

**Highlights:** Practice-changing clinical trial summaries, Hematology and Oncology focus, Simplified trial information, Inclusion and exclusion criteria, Primary endpoints and outcomes, Quick reference tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is SARCULATOR free?

SARCULATOR is free to download, with no in-app purchases.

### Is HemeOncBuddy free?

HemeOncBuddy is free to download, with no in-app purchases.

### Which has better reviews, SARCULATOR or HemeOncBuddy?

HemeOncBuddy is rated higher. SARCULATOR averages 4.3 out of 5 from 3 ratings, while HemeOncBuddy averages 5.0 from 19 ratings.

### Do SARCULATOR or HemeOncBuddy have ads?

Neither SARCULATOR nor HemeOncBuddy shows ads.

### Which is updated more often, SARCULATOR or HemeOncBuddy?

SARCULATOR ships an update every 6 months, and HemeOncBuddy every 24 months. Most recently, SARCULATOR was updated on November 2, 2026 and HemeOncBuddy on November 7, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*